Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jun;6(3):604-607.
doi: 10.21037/tau.2017.04.35.

From PROMIS to PRO-MRI in primary prostate cancer diagnosis

Ivo G Schoots  1 , Monique J Roobol  2
Affiliations
Editorial

From PROMIS to PRO-MRI in primary prostate cancer diagnosis

Ivo G Schoots et al. Transl Androl Urol. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
PROMIS results on diagnostic accuracy of prostate MRI and TRUS-biopsy in the detection of clinically significant prostate cancer using the definition of Gleason score ≥3+4 (4). TMP-Bx, template mapping prostate biopsy; MRI, magnetic resonance imaging; TRUS-Bx, transrectal ultrasound guided biopsy; csPCa, clinically significant prostate cancer; TP, true positive; FP, false positive; TN, true negative; FN, false negative; PPV, positive predictive value; NPV, negative predictive value. Blue: beneficial interpretation of the test results; light red: slightly negative interpretation of the test results; red: negative interpretation of the test results.
See this image and copyright information in PMC

Comment on

References

    1. Schoots IG, Roobol MJ, Nieboer D, et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 2015;68:438-50. 10.1016/j.eururo.2014.11.037 - DOI - PubMed
    1. Valerio M, Donaldson I, Emberton M, et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol 2015;68:8-19. 10.1016/j.eururo.2014.10.026 - DOI - PubMed
    1. Wegelin O, van Melick HH, Hooft L, et al. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique? Eur Urol 2017;71:517-31. 10.1016/j.eururo.2016.07.041 - DOI - PubMed
    1. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017;389:815-22. 10.1016/S0140-6736(16)32401-1 - DOI - PubMed
    1. Roobol MJ, van Vugt HA, Loeb S, et al. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol 2012;61:577-83. 10.1016/j.eururo.2011.11.012 - DOI - PubMed

LinkOut - more resources